Too many men are getting the all-clear for prostate cancer when in fact they have the disease, say doctors, who are calling for an overhaul of testing techniques.

Professor Stephen Langley, a prostate cancer expert, blames the misdiagnoses on inaccurate biopsies.Under current guidelines from NICE (National Institute for Health and Care Excellence), men with abnormally high levels of prostate specific antigen (PSA), a protein produced by the prostate gland, should be offered a test called trans-rectal ultrasound (TRUS) biopsy.

Here, doctors take tissue samples by passing special needles via a probe in the rectum.Read more: http://www.dailymail.co.uk/health/article-3135045/Is-prostate-cancer-test-men-risk-demand.html#ixzz4PX4UkSdj Follow us: @MailOnline on Twitter | DailyMail on Facebook

Read the full article here